SCHEMBL18907252

SCHEMBL18907252

c1ccc(-c2nc3cc4ccccc4cc3c3c2cc(-c2c4ccccc4c(-c4cccc5ccccc45)c4ccccc24)c2ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.44
ESR2 Q92731 6/20 0.44
KDM4E B2RXH2 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
ADORA2A P29274 3/20 0.37
NUDT1 P36639 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 4/20 0.36
MAPT P10636 3/20 0.36
TP53 P04637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPK1 P28482 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034964 0.91 MEN1 (0.42) ESR1ESR2KDM4ESMN1; SMN2LMNA
SCHEMBL18907303 0.86 ESR1 (0.43) ESR1ESR2KDM4ESMN1; SMN2LMNA
SCHEMBL18907270 0.85 ESR1 (0.49) ESR1ESR2KDM4ESMN1; SMN2LMNA
SCHEMBL18907345 0.85 ALDH1A1 (0.42) KDM4ESMN1; SMN2LMNAADORA2ANUDT1
SCHEMBL18914565 0.83 ALDH1A1 (0.41) ESR1ESR2KDM4ELMNAADORA2A
SCHEMBL18907300 0.83 ESR1 (0.44) ESR1ESR2KDM4ESMN1; SMN2ALDH1A1
SCHEMBL18907275 0.82 ESR1 (0.43) ESR1ESR2KDM4ESMN1; SMN2LMNA
SCHEMBL18907243 0.82 ALDH1A1 (0.36) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL18907340 0.82 KDM4E (0.41) ESR1ESR2KDM4ESMN1; SMN2LMNA
SCHEMBL18907184 0.81 ESR1 (0.49) ESR1ESR2KDM4ESMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 ESR1 114/4885ESR2 456/4885KDM4E 2914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.